fig2

Unraveling resistance to immune checkpoint inhibitors in HNSCC: from mechanisms to combination therapies

Figure 2. Mechanisms for immune therapy resistance in HNSCC. Created in BioRender. Yu, Y. (2025) https://BioRender.com/2oorj0t. HNSCC: Head and neck squamous cell carcinoma; MHC-1: major histocompatibility complex-1; PD-L1: programmed death-ligand 1; PD-1: programmed death-1; VEGF: vascular endothelial growth factor.

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/